Failla Memorial Lecture: the future of heavy-ion science in biology and medicine

An extensive review, with over 100 references, of the use of accelerator techniques in radiobiology is presented. Currently, beams of any stable isotope species up to uranium are available at kinetic energies of several hundred MeV/nucleon at the Berkeley Bevalac. The heavy ions hold interest for a broad spectrum of research because of their effectiveness in producing a series of major lesions in DNA along single particle tracks and because of the Bragg depth ionization properties that allow the precise deposition of highly localized doses deep in the human body. Heavy ions, when compared to low-LET radiation, have increased effectiveness for mammalian cell lethality, chromosome mutations, and cell transformation. The molecular mechanisms are not completely understood but appear to involve fragmentation and reintegration of DNA. Heavy ions do not require the presence of oxygen for producing their effects. Heavy ions are effective in delaying or blocking the cell division process. These radiobiological properties, combined with the ability to deliver highly localized internal doses, make accelerated heavy ions potentially important radiotherapeutic tools. Other novel approaches include the utilization of radioactive heavy beams as instant tracers. Heavy-ion radiography and microscopy respond to delicate changes in tissue electron density. The authors laboratory is in the process of proposing a research biomedical heavy-ion accelerator; the availability of such machines would greatly accelerate cancer and brain research with particle beams